Structure-activity relationships of apio nucleosides as potential antiviral agents. 2001

L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
College of Pharmacy, Ewha Womans University, Seoul, Korea.

Several types of novel apio nucleosides were synthesized starting from 1,3-dihydroxyacetone and evaluated for antiviral activity. Among compounds tested, amino substituted apio dideoxynucleosides exhibited anti-HBV activity, while thioapio dideoxynucleosides were found to be active against HIV-1. Apio dideoxydidehydro nucleosides showed moderate to potent anti-HCMV activity, but their bioisosteric thioapio dideoxydidehydro nucleosides did not exhibit any significant antiviral activity.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides

Related Publications

L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
July 2017, Molecules (Basel, Switzerland),
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
January 1991, Pharmaceutical research,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
January 1991, Nucleic acids symposium series,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
January 2001, Nucleic acids research. Supplement (2001),
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
April 2000, Nucleosides, nucleotides & nucleic acids,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
October 2012, European journal of medicinal chemistry,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
June 2000, Journal of medicinal chemistry,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
March 1989, Journal of medicinal chemistry,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
June 1999, Journal of medicinal chemistry,
L S Jeong, and H R Moon, and J H Hong, and S J Yoo, and W J Choi, and H O Kim, and H S Ahn, and H W Baek, and M W Chun, and H D Kim, and J Kim, and J R Choi
May 2003, The Journal of organic chemistry,
Copied contents to your clipboard!